Oliver FitzGerald, MBBCh, BAO, MRCPI, MRCP, FRCPI, MD, is a consultant rheumatologist and Newman Clinical Research Professor at St Vincent's University Hospital and the Conway Institute, University College Dublin (UCD). Professor FitzGerald has published over 250 peer-reviewed papers, many on the subject of spondyloarthropathy. His main research interests include clinical and therapeutic studies; the development of novel imaging techniques; analysis of synovial and skin cellular and cytokine profiles; and, more recently, studies of gene and protein expression in diseased tissue. He currently receives research funding support from the Health Research Board and a number of pharmaceutical companies.
Browse topics
In focus
Bimekizumab: Dual IL-17A/IL-17F inhibition in SpA
Anifrolumab for the treatment of SLE
JAK inhibitor safety: Weighing up the data and understanding the risks
Rituximab and rheumatology practice in the COVID-19 era
Safety snapshot: Upadacitinib in patients with PsA
Repurposing rheumatology drugs for COVID-19
Telemedicine in rheumatology: COVID-19 and beyond
Managing PsA in resource-limited settings
Conferences